Concepts (290)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Smoking Cessation | 22 | 2026 | 306 | 7.770 |
Why?
|
| Electronic Nicotine Delivery Systems | 27 | 2026 | 91 | 7.240 |
Why?
|
| Tobacco Products | 19 | 2024 | 76 | 5.610 |
Why?
|
| Vaping | 15 | 2026 | 57 | 4.480 |
Why?
|
| Cigarette Smoking | 13 | 2026 | 59 | 4.400 |
Why?
|
| Social Media | 12 | 2024 | 118 | 3.290 |
Why?
|
| N-Methyl-3,4-methylenedioxyamphetamine | 12 | 2026 | 80 | 2.990 |
Why?
|
| Affect | 12 | 2026 | 410 | 2.640 |
Why?
|
| Substance Withdrawal Syndrome | 8 | 2024 | 55 | 2.440 |
Why?
|
| Oxytocin | 6 | 2024 | 73 | 2.150 |
Why?
|
| Marketing | 7 | 2022 | 24 | 2.130 |
Why?
|
| Methamphetamine | 9 | 2021 | 111 | 2.090 |
Why?
|
| Tobacco Use Disorder | 8 | 2024 | 130 | 1.950 |
Why?
|
| Central Nervous System Stimulants | 12 | 2018 | 246 | 1.820 |
Why?
|
| Social Facilitation | 3 | 2026 | 9 | 1.780 |
Why?
|
| Hallucinogens | 7 | 2026 | 92 | 1.620 |
Why?
|
| Mindfulness | 2 | 2024 | 29 | 1.620 |
Why?
|
| Emotions | 7 | 2017 | 387 | 1.530 |
Why?
|
| Ethanol | 5 | 2026 | 282 | 1.470 |
Why?
|
| Social Behavior | 9 | 2023 | 316 | 1.410 |
Why?
|
| Young Adult | 40 | 2026 | 7511 | 1.320 |
Why?
|
| Administration, Intranasal | 10 | 2024 | 141 | 1.300 |
Why?
|
| Tobacco Industry | 3 | 2024 | 7 | 1.280 |
Why?
|
| Flavoring Agents | 6 | 2021 | 11 | 1.250 |
Why?
|
| Nicotine | 11 | 2025 | 218 | 1.200 |
Why?
|
| Video Games | 2 | 2021 | 14 | 1.190 |
Why?
|
| Dextroamphetamine | 6 | 2018 | 108 | 1.140 |
Why?
|
| Motivation | 8 | 2022 | 343 | 1.140 |
Why?
|
| Depression | 6 | 2025 | 615 | 1.090 |
Why?
|
| Adult | 54 | 2026 | 29564 | 1.090 |
Why?
|
| Alcohol Drinking | 2 | 2026 | 301 | 1.070 |
Why?
|
| Smokers | 4 | 2021 | 64 | 1.030 |
Why?
|
| Double-Blind Method | 22 | 2020 | 1783 | 1.020 |
Why?
|
| Humans | 100 | 2026 | 98135 | 1.010 |
Why?
|
| Substance-Related Disorders | 9 | 2023 | 470 | 0.970 |
Why?
|
| Smoking | 11 | 2023 | 674 | 0.960 |
Why?
|
| Psychomotor Performance | 7 | 2011 | 508 | 0.950 |
Why?
|
| Alcoholism | 2 | 2026 | 197 | 0.930 |
Why?
|
| Male | 62 | 2026 | 47109 | 0.920 |
Why?
|
| Adolescent | 34 | 2025 | 10097 | 0.880 |
Why?
|
| Female | 63 | 2026 | 51570 | 0.870 |
Why?
|
| Underage Drinking | 3 | 2021 | 4 | 0.850 |
Why?
|
| Adolescent Behavior | 7 | 2020 | 118 | 0.830 |
Why?
|
| Students | 5 | 2021 | 196 | 0.790 |
Why?
|
| Dehydroepiandrosterone | 1 | 2023 | 47 | 0.780 |
Why?
|
| Tobacco Use Cessation | 1 | 2023 | 15 | 0.780 |
Why?
|
| Cognitive Dysfunction | 1 | 2025 | 209 | 0.730 |
Why?
|
| Mobile Applications | 1 | 2023 | 83 | 0.730 |
Why?
|
| Tobacco Use | 7 | 2022 | 36 | 0.710 |
Why?
|
| Blood Pressure | 7 | 2016 | 910 | 0.680 |
Why?
|
| Heart Rate | 6 | 2016 | 536 | 0.680 |
Why?
|
| Binge Drinking | 1 | 2021 | 19 | 0.650 |
Why?
|
| Self Efficacy | 1 | 2021 | 65 | 0.650 |
Why?
|
| Risk-Taking | 2 | 2021 | 159 | 0.640 |
Why?
|
| Amphetamine-Related Disorders | 3 | 2012 | 29 | 0.630 |
Why?
|
| Healthy Volunteers | 5 | 2018 | 153 | 0.630 |
Why?
|
| Intention | 4 | 2026 | 55 | 0.620 |
Why?
|
| Sleep | 4 | 2011 | 469 | 0.610 |
Why?
|
| Sleep Disorders, Circadian Rhythm | 2 | 2010 | 12 | 0.610 |
Why?
|
| Consumer Behavior | 1 | 2019 | 35 | 0.590 |
Why?
|
| Cognition | 6 | 2015 | 673 | 0.580 |
Why?
|
| Behavior, Addictive | 3 | 2023 | 140 | 0.580 |
Why?
|
| Analgesics, Opioid | 5 | 2025 | 539 | 0.570 |
Why?
|
| Personality | 3 | 2015 | 140 | 0.550 |
Why?
|
| Health Education | 1 | 2018 | 109 | 0.540 |
Why?
|
| Attitude to Health | 2 | 2018 | 217 | 0.540 |
Why?
|
| Amphetamine | 2 | 2016 | 105 | 0.540 |
Why?
|
| Dose-Response Relationship, Drug | 10 | 2016 | 1950 | 0.530 |
Why?
|
| Surveys and Questionnaires | 14 | 2026 | 3022 | 0.520 |
Why?
|
| Social Networking | 1 | 2018 | 96 | 0.520 |
Why?
|
| California | 4 | 2026 | 169 | 0.520 |
Why?
|
| Impulsive Behavior | 3 | 2019 | 295 | 0.500 |
Why?
|
| Music | 3 | 2022 | 36 | 0.500 |
Why?
|
| Social Environment | 2 | 2016 | 199 | 0.490 |
Why?
|
| Marijuana Use | 3 | 2020 | 13 | 0.470 |
Why?
|
| Individuality | 2 | 2018 | 120 | 0.460 |
Why?
|
| Choice Behavior | 3 | 2014 | 164 | 0.420 |
Why?
|
| Serotonin Agents | 1 | 2014 | 14 | 0.420 |
Why?
|
| Empathy | 2 | 2015 | 154 | 0.400 |
Why?
|
| Alcoholic Intoxication | 1 | 2013 | 39 | 0.380 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2013 | 42 | 0.370 |
Why?
|
| Minority Groups | 2 | 2024 | 156 | 0.370 |
Why?
|
| Cross-Sectional Studies | 7 | 2025 | 2037 | 0.350 |
Why?
|
| Parents | 2 | 2025 | 321 | 0.340 |
Why?
|
| Self Report | 7 | 2022 | 355 | 0.330 |
Why?
|
| Sex Factors | 2 | 2024 | 1138 | 0.330 |
Why?
|
| Eating | 1 | 2011 | 164 | 0.320 |
Why?
|
| Neoplasms | 2 | 2023 | 3334 | 0.310 |
Why?
|
| Hypnotics and Sedatives | 2 | 2013 | 143 | 0.310 |
Why?
|
| Health Behavior | 2 | 2022 | 200 | 0.310 |
Why?
|
| Ecological Momentary Assessment | 2 | 2026 | 57 | 0.280 |
Why?
|
| Reward | 5 | 2019 | 226 | 0.280 |
Why?
|
| Pyridines | 1 | 2010 | 318 | 0.280 |
Why?
|
| Stress, Psychological | 2 | 2026 | 383 | 0.270 |
Why?
|
| Los Angeles | 5 | 2020 | 29 | 0.270 |
Why?
|
| Internal-External Control | 1 | 2007 | 47 | 0.260 |
Why?
|
| Research Design | 2 | 2026 | 660 | 0.260 |
Why?
|
| Anxiety | 3 | 2026 | 370 | 0.260 |
Why?
|
| Speech | 2 | 2020 | 93 | 0.250 |
Why?
|
| Psychotropic Drugs | 2 | 2020 | 82 | 0.250 |
Why?
|
| Psychotherapy | 2 | 2026 | 76 | 0.250 |
Why?
|
| Risk Factors | 7 | 2026 | 6232 | 0.240 |
Why?
|
| Self Administration | 3 | 2012 | 78 | 0.240 |
Why?
|
| Anxiety Disorders | 3 | 2019 | 160 | 0.240 |
Why?
|
| Middle Aged | 11 | 2026 | 29442 | 0.230 |
Why?
|
| Prospective Studies | 3 | 2026 | 4825 | 0.230 |
Why?
|
| Arousal | 3 | 2018 | 177 | 0.230 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2021 | 658 | 0.230 |
Why?
|
| Pamphlets | 1 | 2025 | 14 | 0.220 |
Why?
|
| Exercise | 2 | 2020 | 380 | 0.220 |
Why?
|
| Awareness | 1 | 2025 | 93 | 0.220 |
Why?
|
| Nicotine Chewing Gum | 1 | 2024 | 3 | 0.210 |
Why?
|
| Administration, Oral | 4 | 2018 | 674 | 0.210 |
Why?
|
| Hostility | 1 | 2024 | 28 | 0.210 |
Why?
|
| Dehydroepiandrosterone Sulfate | 1 | 2023 | 14 | 0.200 |
Why?
|
| Attentional Bias | 1 | 2023 | 10 | 0.200 |
Why?
|
| Product Labeling | 2 | 2013 | 4 | 0.200 |
Why?
|
| Alkaloids | 2 | 2013 | 48 | 0.190 |
Why?
|
| United States | 8 | 2025 | 8193 | 0.190 |
Why?
|
| Buprenorphine | 1 | 2024 | 57 | 0.190 |
Why?
|
| Pain Management | 1 | 2025 | 194 | 0.190 |
Why?
|
| Drug Overdose | 1 | 2024 | 103 | 0.180 |
Why?
|
| Schools | 2 | 2020 | 93 | 0.180 |
Why?
|
| Sexual and Gender Minorities | 1 | 2026 | 262 | 0.180 |
Why?
|
| Longitudinal Studies | 1 | 2026 | 1284 | 0.180 |
Why?
|
| Marijuana Smoking | 2 | 2019 | 32 | 0.170 |
Why?
|
| Racism | 1 | 2023 | 107 | 0.170 |
Why?
|
| Patient Education as Topic | 1 | 2025 | 417 | 0.170 |
Why?
|
| Smoke | 1 | 2021 | 29 | 0.170 |
Why?
|
| Clinical Trials as Topic | 1 | 2026 | 1131 | 0.160 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2025 | 601 | 0.160 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2021 | 76 | 0.160 |
Why?
|
| Pain | 2 | 2024 | 416 | 0.160 |
Why?
|
| Premenopause | 1 | 2020 | 65 | 0.160 |
Why?
|
| Plants, Edible | 1 | 2019 | 2 | 0.150 |
Why?
|
| Internet | 2 | 2020 | 358 | 0.150 |
Why?
|
| Opioid-Related Disorders | 1 | 2024 | 255 | 0.150 |
Why?
|
| Pharmaceutical Preparations | 1 | 2021 | 109 | 0.150 |
Why?
|
| Product Packaging | 1 | 2019 | 1 | 0.150 |
Why?
|
| Government Regulation | 1 | 2019 | 49 | 0.150 |
Why?
|
| Work Schedule Tolerance | 2 | 2010 | 34 | 0.150 |
Why?
|
| Aromatherapy | 1 | 2019 | 1 | 0.150 |
Why?
|
| Mood Disorders | 1 | 2020 | 86 | 0.150 |
Why?
|
| Taste | 1 | 2019 | 29 | 0.150 |
Why?
|
| Antidepressive Agents | 1 | 2020 | 118 | 0.150 |
Why?
|
| Cannabis | 1 | 2019 | 41 | 0.150 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2019 | 63 | 0.140 |
Why?
|
| Behavior Therapy | 1 | 2020 | 100 | 0.140 |
Why?
|
| Pleasure | 2 | 2015 | 14 | 0.140 |
Why?
|
| Cartoons as Topic | 1 | 2018 | 3 | 0.140 |
Why?
|
| Commerce | 1 | 2018 | 29 | 0.140 |
Why?
|
| Pilot Projects | 2 | 2019 | 977 | 0.140 |
Why?
|
| Language | 1 | 2020 | 166 | 0.140 |
Why?
|
| Economics, Behavioral | 1 | 2018 | 8 | 0.140 |
Why?
|
| Attitude | 1 | 2018 | 133 | 0.130 |
Why?
|
| Drug Interactions | 2 | 2015 | 239 | 0.130 |
Why?
|
| Neuropsychological Tests | 1 | 2020 | 569 | 0.130 |
Why?
|
| Cluster Analysis | 1 | 2018 | 402 | 0.130 |
Why?
|
| Anhedonia | 1 | 2017 | 22 | 0.130 |
Why?
|
| Health Promotion | 1 | 2018 | 176 | 0.130 |
Why?
|
| Progesterone | 1 | 2017 | 126 | 0.130 |
Why?
|
| Patient Selection | 1 | 2021 | 725 | 0.120 |
Why?
|
| Designer Drugs | 2 | 2013 | 4 | 0.120 |
Why?
|
| Estradiol | 1 | 2017 | 268 | 0.120 |
Why?
|
| Pharmacogenomic Variants | 1 | 2016 | 46 | 0.120 |
Why?
|
| Comorbidity | 2 | 2017 | 1031 | 0.120 |
Why?
|
| Principal Component Analysis | 2 | 2016 | 170 | 0.120 |
Why?
|
| Receptors, Oxytocin | 1 | 2016 | 12 | 0.120 |
Why?
|
| Self-Control | 1 | 2016 | 14 | 0.120 |
Why?
|
| Neuropeptides | 1 | 2016 | 113 | 0.120 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2016 | 33 | 0.120 |
Why?
|
| Premenstrual Syndrome | 1 | 2016 | 9 | 0.120 |
Why?
|
| Neurotransmitter Agents | 1 | 2016 | 102 | 0.120 |
Why?
|
| Panic Disorder | 1 | 2015 | 21 | 0.120 |
Why?
|
| Craving | 1 | 2016 | 30 | 0.110 |
Why?
|
| Visual Analog Scale | 1 | 2015 | 18 | 0.110 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2015 | 29 | 0.110 |
Why?
|
| Cadherins | 1 | 2016 | 184 | 0.110 |
Why?
|
| Cross-Over Studies | 2 | 2016 | 410 | 0.110 |
Why?
|
| Autism Spectrum Disorder | 1 | 2016 | 95 | 0.110 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2015 | 508 | 0.110 |
Why?
|
| Social Class | 1 | 2015 | 156 | 0.100 |
Why?
|
| Time Factors | 2 | 2014 | 5576 | 0.100 |
Why?
|
| Psychoses, Substance-Induced | 1 | 2013 | 7 | 0.100 |
Why?
|
| Drug and Narcotic Control | 1 | 2013 | 8 | 0.100 |
Why?
|
| Diphenhydramine | 1 | 2013 | 14 | 0.100 |
Why?
|
| Breath Tests | 1 | 2013 | 59 | 0.100 |
Why?
|
| Focus Groups | 2 | 2025 | 214 | 0.100 |
Why?
|
| Genome-Wide Association Study | 3 | 2016 | 1850 | 0.100 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2016 | 2558 | 0.100 |
Why?
|
| Emergency Treatment | 1 | 2013 | 47 | 0.090 |
Why?
|
| Euphoria | 1 | 2013 | 47 | 0.090 |
Why?
|
| Linear Models | 1 | 2014 | 424 | 0.090 |
Why?
|
| Pharmacogenetics | 1 | 2016 | 472 | 0.090 |
Why?
|
| Photic Stimulation | 2 | 2014 | 527 | 0.090 |
Why?
|
| Psychomotor Disorders | 1 | 2012 | 20 | 0.090 |
Why?
|
| Fear | 1 | 2013 | 91 | 0.090 |
Why?
|
| New York | 1 | 2012 | 79 | 0.090 |
Why?
|
| HIV Infections | 1 | 2021 | 1018 | 0.090 |
Why?
|
| United States Food and Drug Administration | 2 | 2024 | 164 | 0.080 |
Why?
|
| Reproducibility of Results | 2 | 2015 | 2787 | 0.080 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 1784 | 0.080 |
Why?
|
| Work | 1 | 2010 | 15 | 0.080 |
Why?
|
| Retrospective Studies | 2 | 2023 | 10962 | 0.080 |
Why?
|
| Ambulatory Care | 1 | 2012 | 201 | 0.080 |
Why?
|
| Hemodynamics | 1 | 2014 | 747 | 0.080 |
Why?
|
| Administration, Cutaneous | 2 | 2020 | 66 | 0.070 |
Why?
|
| Cohort Studies | 3 | 2023 | 3213 | 0.070 |
Why?
|
| Wakefulness | 1 | 2008 | 130 | 0.070 |
Why?
|
| Adrenergic Agents | 1 | 2007 | 6 | 0.070 |
Why?
|
| Fatigue | 1 | 2008 | 187 | 0.070 |
Why?
|
| Orientation | 1 | 2007 | 111 | 0.060 |
Why?
|
| Behavior | 1 | 2007 | 86 | 0.060 |
Why?
|
| Homosexuality | 1 | 1987 | 10 | 0.060 |
Why?
|
| Judgment | 1 | 2007 | 69 | 0.060 |
Why?
|
| Mother-Child Relations | 1 | 1987 | 30 | 0.060 |
Why?
|
| Maternal Behavior | 1 | 1987 | 56 | 0.060 |
Why?
|
| Pattern Recognition, Visual | 1 | 2007 | 163 | 0.060 |
Why?
|
| Selection, Genetic | 1 | 1990 | 571 | 0.060 |
Why?
|
| Delphi Technique | 1 | 2026 | 181 | 0.060 |
Why?
|
| Cardiovascular Diseases | 1 | 2012 | 802 | 0.050 |
Why?
|
| Models, Genetic | 1 | 1990 | 1005 | 0.050 |
Why?
|
| Chewing Gum | 1 | 2024 | 4 | 0.050 |
Why?
|
| Heroin | 1 | 2024 | 15 | 0.050 |
Why?
|
| Psychometrics | 2 | 2015 | 357 | 0.050 |
Why?
|
| Baths | 2 | 2013 | 10 | 0.050 |
Why?
|
| Salts | 2 | 2013 | 18 | 0.050 |
Why?
|
| Menthol | 1 | 2022 | 6 | 0.050 |
Why?
|
| Fentanyl | 1 | 2024 | 92 | 0.050 |
Why?
|
| Ice | 1 | 2022 | 11 | 0.050 |
Why?
|
| Multifactorial Inheritance | 2 | 2015 | 235 | 0.050 |
Why?
|
| Biological Evolution | 1 | 1990 | 1072 | 0.040 |
Why?
|
| Laboratories | 1 | 2022 | 47 | 0.040 |
Why?
|
| Needle Sharing | 1 | 2021 | 16 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 4026 | 0.040 |
Why?
|
| Psycholinguistics | 1 | 2020 | 10 | 0.040 |
Why?
|
| Drug Prescriptions | 1 | 2021 | 157 | 0.040 |
Why?
|
| Adolescent Health | 1 | 2019 | 5 | 0.040 |
Why?
|
| Semantics | 1 | 2020 | 57 | 0.040 |
Why?
|
| Sex Distribution | 1 | 2019 | 176 | 0.040 |
Why?
|
| Temperament | 1 | 2019 | 29 | 0.040 |
Why?
|
| Tobacco, Smokeless | 1 | 2018 | 11 | 0.040 |
Why?
|
| Depressive Disorder | 1 | 2019 | 231 | 0.030 |
Why?
|
| Models, Psychological | 1 | 2018 | 166 | 0.030 |
Why?
|
| Multilevel Analysis | 1 | 2016 | 26 | 0.030 |
Why?
|
| Saliva | 1 | 2017 | 134 | 0.030 |
Why?
|
| Diet | 1 | 2020 | 469 | 0.030 |
Why?
|
| Ovary | 1 | 2017 | 260 | 0.030 |
Why?
|
| Age Factors | 1 | 2021 | 1967 | 0.030 |
Why?
|
| Models, Statistical | 1 | 2019 | 601 | 0.030 |
Why?
|
| Ganglionic Stimulants | 1 | 2015 | 7 | 0.030 |
Why?
|
| Cell Phone | 1 | 2016 | 39 | 0.030 |
Why?
|
| Placebos | 1 | 2016 | 209 | 0.030 |
Why?
|
| Neuroticism | 1 | 2015 | 6 | 0.030 |
Why?
|
| Guanylate Kinases | 1 | 2015 | 12 | 0.030 |
Why?
|
| Genotyping Techniques | 1 | 2016 | 72 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 2021 | 685 | 0.030 |
Why?
|
| Anticipation, Psychological | 1 | 2015 | 11 | 0.030 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 1 | 2015 | 16 | 0.030 |
Why?
|
| Heterozygote | 1 | 2016 | 390 | 0.030 |
Why?
|
| Cell Adhesion Molecules | 1 | 2015 | 184 | 0.030 |
Why?
|
| Child | 2 | 2021 | 7699 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2016 | 889 | 0.030 |
Why?
|
| Data Collection | 1 | 2015 | 376 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2018 | 850 | 0.030 |
Why?
|
| Psychological Tests | 1 | 2014 | 89 | 0.030 |
Why?
|
| Interpersonal Relations | 1 | 2015 | 182 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2021 | 1109 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2015 | 726 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2015 | 312 | 0.020 |
Why?
|
| Social Marketing | 1 | 2013 | 11 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2020 | 9713 | 0.020 |
Why?
|
| Poison Control Centers | 1 | 2013 | 19 | 0.020 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2013 | 54 | 0.020 |
Why?
|
| Health Status Disparities | 1 | 2015 | 234 | 0.020 |
Why?
|
| Global Health | 1 | 2013 | 215 | 0.020 |
Why?
|
| Visual Perception | 1 | 2014 | 350 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 7387 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 1990 | 351 | 0.020 |
Why?
|
| Child Rearing | 1 | 1987 | 4 | 0.020 |
Why?
|
| Father-Child Relations | 1 | 1987 | 4 | 0.020 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2007 | 226 | 0.020 |
Why?
|
| Gender Identity | 1 | 1987 | 59 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 2555 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2007 | 313 | 0.010 |
Why?
|
| Life Style | 1 | 1987 | 193 | 0.010 |
Why?
|
| Social Support | 1 | 1987 | 246 | 0.010 |
Why?
|
| Aged | 1 | 2019 | 21760 | 0.010 |
Why?
|
| Child, Preschool | 1 | 1987 | 4006 | 0.010 |
Why?
|
| Animals | 1 | 1990 | 28902 | 0.000 |
Why?
|